1
TÍTULO: The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-to-Severely Active Ulcerative Colitis
AUTORES: Siegmund, Britta; Sands, Bruce E.; Samaan, Karen; Li, Xingyuan; Morris, Nathan; Gibble, Theresa Hunter; Redondo, Isabel; Lissoos, Trevor; D'Haens, Geert;
PUBLICAÇÃO: 2022, FONTE: AMERICAN JOURNAL OF GASTROENTEROLOGY, VOLUME: 117, NÚMERO: 10
INDEXADO EM: WOS